Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay
Yuanhao Liang(Chinese Center For Disease Control and Prevention), Shixing Tang(Southern Medical University), Baisheng Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingdiao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Xingfen Yang(Southern Medical University), Lirong Zou(Chinese Academy of Medical Sciences & Peking Union Medical College), Haiying Wang(Southern Medical University), Jianhui Zhao(Second Affiliated Hospital of Zhejiang University), Yanling Mo(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongqing Lin(Southern Medical University), Xiaoling Deng(ShanghaiTech University), Jiufeng Sun(Sun Yat-sen University)
Cited by 34
Related Papers
Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome
|Genome Medicine|2023|178
Global, regional, and national prevalence and trends of infertility among individuals of reproductive age (15–49 years) from 1990 to 2021, with projections to 2040
|Human Reproduction|2025|130
<i>Fonsecaea nubica</i>sp. nov, a new agent of human chromoblastomycosis revealed using molecular data
|Medical Mycology|2010|96
Cyphellophora and its relatives in Phialophora: biodiversity and possible role in human infection
|Fungal Diversity|2012|89